Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.
about
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.Combination therapy with low molecular weight heparin and Adriamycin results in decreased breast cancer cell metastasis in C3H mice.Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppressionLow-molecular-weight heparins and cancer: focus on antitumoral effect.Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axisHeparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease.Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase.The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells.In vitro anticancer effects of a RAGE inhibitor discovered using a structure-based drug design system.Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression.Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma
P2860
Q33808326-ED08245C-3ACB-46FD-9201-C3C9A3709096Q34119737-392081EC-E1AF-476D-B803-CE067775AE92Q37295230-710A333A-A205-4711-ACEC-2157C5BE89B5Q38376242-131866F8-B38B-401A-8BE3-12CE263696F1Q38686477-01B951CF-DFAE-4BF0-B729-F1834A37A3CFQ38737938-A4404B1D-5387-4800-9F51-FA8054942969Q39281099-2CECF25E-11F5-49E5-9DB7-0B0F38DA9A34Q40714729-3B5FA944-00D2-4C0C-B43E-1D7A43A450C3Q42251558-FC3533AB-73C9-4583-99F3-44DC12242B14Q52655131-52B4D5C1-DE03-4D7B-86B7-AC8C70159D53Q54939383-212DA300-4585-463E-9089-29A21B4302ACQ58693989-1D035CCF-8CB3-41DC-9A25-CE299B7B2F85
P2860
Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Low molecular weight heparin s ...... e in human fibrosarcoma cells.
@en
Low molecular weight heparin s ...... e in human fibrosarcoma cells.
@nl
type
label
Low molecular weight heparin s ...... e in human fibrosarcoma cells.
@en
Low molecular weight heparin s ...... e in human fibrosarcoma cells.
@nl
prefLabel
Low molecular weight heparin s ...... e in human fibrosarcoma cells.
@en
Low molecular weight heparin s ...... e in human fibrosarcoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Low molecular weight heparin s ...... pe in human fibrosarcoma cells
@en
P2093
Ai Harashima
Hideto Yonekura
Hiroshi Yamamoto
Hiroyuki Tsuchiya
Seiichi Munesue
Takuo Watanabe
Yasuhiko Yamamoto
P2860
P304
P356
10.1111/CAS.12133
P577
2013-03-24T00:00:00Z